Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001215495 | SCV001387243 | uncertain significance | Charcot-Marie-Tooth disease, axonal, type 2z | 2019-10-02 | criteria provided, single submitter | clinical testing | This sequence change replaces alanine with valine at codon 406 of the MORC2 protein (p.Ala406Val). The alanine residue is moderately conserved and there is a small physicochemical difference between alanine and valine This variant is not present in population databases (ExAC no frequency). This variant has been observed in a family affected with Charcot-Marie-Tooth disease type 2 (Invitae). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Genesis Genome Database | RCV000857119 | SCV000999697 | uncertain significance | Charcot-Marie-Tooth disease | 2019-08-14 | no assertion criteria provided | research | |
Inherited Neuropathy Consortium | RCV001027506 | SCV001190081 | uncertain significance | not provided | no assertion criteria provided | provider interpretation |